NCT02377271View on ClinicalTrials.gov

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Ischemic Optic Neuropathy
Interventions
DRUG

bosentan

treatment by bosentan or placebo is randomized , 125 mg twice a day

DRUG

placebo

treatment by bosentan or placebo is randomized

Trial Locations (7)

33000

TERMINATED

University Hospital of Bordeaux, Bordeaux

38043

RECRUITING

CHU de Grenoble, Grenoble

RECRUITING

University Hospital of Grenoble Michallon, Grenoble

42055

RECRUITING

University hospital of Saint-Etienne, Saint-Etienne

49100

RECRUITING

University Hospital of Angers, Angers

75019

RECRUITING

Ophtalmological fondation of Rothschild + Bichat Hospital, Paris

Unknown

RECRUITING

Centre National d'Ophtalmologie XV-XX, Paris

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02377271 - ENDOTHELION Study Group: Effect of Bosentan in NAION Patients | Biotech Hunter | Biotech Hunter